Physical activity and exercise: Strategies to manage frailty
Instituto Ramón y Cajal de Investigación Sanitaria · Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable · +3 more institutions
Abstract
Frailty, a consequence of the interaction of the aging process and certain chronic diseases, compromises functional outcomes in the elderly and substantially increases their risk for developing disabilities and other adverse outcomes. Frailty follows from the combination of several impaired physiological mechanisms affecting multiple organs and systems. And, though frailty and sarcopenia are related, they are two different conditions. Thus, strategies to preserve or improve functional status should consider systemic function in addition to muscle conditioning. Physical activity/exercise is considered one of the main strategies to counteract frailty-related physical impairment in the elderly. Exercise reduces…
Citation impact
- FWCI
- 31.39
- Percentile
- 100%
- References
- 336
Authors
4- JAJavier Angulo
Instituto Ramón y Cajal de Investigación Sanitaria, Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable, Hospital Universitario Ramón y Cajal, Instituto de Salud Carlos III
- MEMariam El Assar
Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable, Hospital Universitario de Getafe, Instituto de Salud Carlos III
- AÁAlejandro Álvarez‐Bustos
Hospital Universitario de Getafe
- LRLeocadio Rodríguez‐MañasCorresponding
Hospital Universitario de Getafe, Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable
Topics & keywords
- Myokine
- Sarcopenia
- Flexibility (engineering)
- Medicine
- Physical medicine and rehabilitation
- Intervention (counseling)
- Psychological intervention
- Aerobic exercise
Funding
- CDCentro de Investigación Biomédica en Red Fragilidad y Envejecimiento SaludableAward: CB16/10/00464
- FGFURTHERMORE grants in publishing
- ECEuropean CommissionAwards: FP7/2007-2013, 305483, 2007-2013, FP7/2007, CB16/10/00464, 115621
- FEFederación Española de Enfermedades Raras
- MDMinisterio de Economía y CompetitividadAward: CB16/10/00464
- IMInnovative Medicines InitiativeAwards: 115621, IMI-JU 115621, FP7/2007-2013
- IDInstituto de Salud Carlos IIIAwards: CB16/10/00464, PI15/00674, PI15/01160